Research on Complex Generics

The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars. Only the following applicant is eligible to apply for this single source funding: The University of Maryland Patrick Johnson Grants Management Specialist Food and Drug Administration